Literature DB >> 20298833

Psychometric validation of the Manual Ability Measure-36 (MAM-36) in patients with neurologic and musculoskeletal disorders.

Christine C Chen1, Rita K Bode.   

Abstract

OBJECTIVES: To evaluate the psychometric properties of the Manual Ability Measure-36 (MAM-36), a new hand function outcome measure, and to examine differences in manual abilities and item parameters in patients with neurologic and musculoskeletal conditions.
DESIGN: Convenience sample from 2 time periods, cross-sectional.
SETTING: Outpatient rehabilitation units and private hand clinics. PARTICIPANTS: Patients (N=337; mean age, 50.3+/-14.9y) with a variety of neurologic and musculoskeletal (orthopedic) diagnoses. Most of these individuals were community dwelling, and all had residual functional limitations in the hand(s).
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Rasch analysis was performed on MAM-36 data to evaluate both scale structure and psychometric properties, which include rating distribution, step measures, item fit, separation, and dimensionality. A t test was performed to examine the differences in manual abilities in patients with the 2 conditions. Uniform differential item functioning (DIF) between neurologic and musculoskeletal groups was examined. (DIF occurs when subgroup members within the sample with the same level of the underlying trait being measured respond differently to an individual item.) Manual ability estimates were recalibrated with step and common item anchoring; they were compared with those derived from the original analysis.
RESULTS: The 36 items measured a single construct with no misfitting items. The scale was used as intended. The items can reliably separate the participants into 5 ability strata. Neurologic patients had a significantly lower mean manual ability than musculoskeletal patients. Fourteen items exhibited DIF. However, DIF had no effect on either scale quality or calibration of manual ability. We decided that a single rating scale is appropriate for both groups.
CONCLUSIONS: This study showed that the MAM-36 has more than adequate psychometric properties and can be used as a generic outcome measure for patients with a wide variety of clinical diagnoses. Copyright 2010 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20298833     DOI: 10.1016/j.apmr.2009.11.012

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  14 in total

1.  Cross-cultural adaptation and psychometric properties of the Turkish version of the Manual Ability Measure-36 (MAM-36) in people with multiple sclerosis.

Authors:  Ozge Ertekin; Turhan Kahraman; Mona Aras; Cavid Baba; Serkan Ozakbas
Journal:  Neurol Sci       Date:  2020-11-24       Impact factor: 3.307

Review 2.  Performance Measures for Upper Extremity Functions in Persons with Multiple Sclerosis.

Authors:  Turhan Kahraman
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

3.  Phase II Randomized Controlled Trial of Constraint-Induced Movement Therapy in Multiple Sclerosis. Part 1: Effects on Real-World Function.

Authors:  Victor W Mark; Edward Taub; Gitendra Uswatte; David M Morris; Gary R Cutter; Terrie L Adams; Mary H Bowman; Staci McKay
Journal:  Neurorehabil Neural Repair       Date:  2018-03       Impact factor: 3.919

4.  Motor ability, function, and health-related quality of life as correlates of symptom burden in patients with sclerotic chronic graft-versus-host disease receiving imatinib mesylate.

Authors:  Emily A Rosenthal; Pei-Shu Ho; Galen O Joe; Sandra A Mitchell; Susan Booher; Steven Z Pavletic; Kristin Baird; Edward W Cowen; Leora E Comis
Journal:  Support Care Cancer       Date:  2019-12-06       Impact factor: 3.603

5.  Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease.

Authors:  Kristin Baird; Leora E Comis; Galen O Joe; Seth M Steinberg; Fran T Hakim; Jeremy J Rose; Sandra A Mitchell; Steven Z Pavletic; William D Figg; Lawrence Yao; Kathleen C Flanders; Naoko Takebe; Stefanie Sarantopoulos; Susan Booher; Edward W Cowen
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-12       Impact factor: 5.742

6.  Using Rasch Analysis to Validate the Michigan Hand Outcomes Questionnaire from the Wrist and Radius Injury Surgical Trial.

Authors:  Mayank Jayaram; Chang Wang B S; Melissa J Shauver; Lu Wang; Kevin C Chung
Journal:  Plast Reconstr Surg       Date:  2021-10-01       Impact factor: 5.169

7.  Italian validation of the Arm Function in Multiple Sclerosis Questionnaire (AMSQ).

Authors:  Andrea Tacchino; Michela Ponzio; Ludovico Pedullà; Jessica Podda; Margherita Monti Bragadin; Elisabetta Pedrazzoli; Giovanna Konrad; Mario Alberto Battaglia; Lidwine Mokkink; Giampaolo Brichetto
Journal:  Neurol Sci       Date:  2020-05-12       Impact factor: 3.307

Review 8.  Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice.

Authors:  Catherine Ball; Anna L Pratt; Jagdeep Nanchahal
Journal:  BMC Musculoskelet Disord       Date:  2013-04-10       Impact factor: 2.362

Review 9.  Rehabilitation for distal radial fractures in adults.

Authors:  Helen H G Handoll; Joanne Elliott
Journal:  Cochrane Database Syst Rev       Date:  2015-09-25

Review 10.  Measurement invariance across chronic conditions: a systematic review and an empirical investigation of the Health Education Impact Questionnaire (heiQ™).

Authors:  Michael Schuler; Gunda Musekamp; Jürgen Bengel; Sandra Nolte; Richard H Osborne; Hermann Faller
Journal:  Health Qual Life Outcomes       Date:  2014-04-23       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.